Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics (Nasdaq: AKBA) has scheduled the release of its fourth quarter and full year 2024 financial results on Thursday, March 13, 2025, before market open. The company will host a conference call at 8:00 a.m. ET on the same day to discuss the financial performance and recent business developments.
Investors and interested parties can access the conference call through a registration link, with recommended dial-in 15 minutes before the scheduled start time. A live webcast will be available through the Investors section of Akebia's website, with an online archive accessible afterward at ir.akebia.com.
Akebia Therapeutics (Nasdaq: AKBA) ha programmato la pubblicazione dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 13 marzo 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:00 a.m. ET nello stesso giorno per discutere delle performance finanziarie e degli sviluppi recenti nel business.
Gli investitori e le parti interessate possono accedere alla conferenza telefonica tramite un link di registrazione, con una chiamata consigliata 15 minuti prima dell'orario di inizio programmato. Una diretta streaming sarà disponibile nella sezione Investitori del sito web di Akebia, con un archivio online accessibile successivamente su ir.akebia.com.
Akebia Therapeutics (Nasdaq: AKBA) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 13 de marzo de 2025, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia a las 8:00 a.m. ET el mismo día para discutir el rendimiento financiero y los recientes desarrollos comerciales.
Los inversores y las partes interesadas pueden acceder a la llamada de conferencia a través de un enlace de registro, con una llamada recomendada 15 minutos antes de la hora de inicio programada. Se dispondrá de una transmisión en vivo a través de la sección de Inversores del sitio web de Akebia, con un archivo en línea accesible posteriormente en ir.akebia.com.
Akebia Therapeutics (Nasdaq: AKBA)는 2025년 3월 13일 목요일, 시장 개장 전에 2024년 4분기 및 연간 재무 결과를 발표할 예정입니다. 회사는 같은 날 오전 8시(ET)에 재무 성과 및 최근 비즈니스 개발에 대해 논의하기 위한 컨퍼런스 콜을 주최합니다.
투자자 및 이해관계자는 등록 링크를 통해 컨퍼런스 콜에 접근할 수 있으며, 예정된 시작 시간 15분 전에 전화 연결을 권장합니다. Akebia 웹사이트의 투자자 섹션을 통해 생중계가 제공되며, 이후 ir.akebia.com에서 온라인 아카이브에 접근할 수 있습니다.
Akebia Therapeutics (Nasdaq: AKBA) a prévu de publier ses résultats financiers du quatrième trimestre et de l'année 2024 le jeudi 13 mars 2025, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h00 (ET) le même jour pour discuter de la performance financière et des récents développements commerciaux.
Les investisseurs et les parties intéressées peuvent accéder à la conférence téléphonique via un lien d'inscription, avec une connexion recommandée 15 minutes avant l'heure de début prévue. Un webinaire en direct sera disponible dans la section Investisseurs du site web d'Akebia, avec un archive en ligne accessible par la suite sur ir.akebia.com.
Akebia Therapeutics (Nasdaq: AKBA) hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf Donnerstag, den 13. März 2025, vor Markteröffnung angesetzt. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz abhalten, um die finanzielle Leistung und die aktuellen Geschäftsentwicklungen zu besprechen.
Investoren und interessierte Parteien können über einen Registrierungslink auf die Telefonkonferenz zugreifen, wobei eine Einwahl 15 Minuten vor dem geplanten Beginn empfohlen wird. Ein Live-Webcast wird über den Investorenbereich der Akebia-Website verfügbar sein, mit einem später zugänglichen Online-Archiv unter ir.akebia.com.
- None.
- None.
Akebia to Host Conference Call on March 13, 2025, at 8:00 a.m. ET
CAMBRIDGE, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2024, on Thursday, March 13, 2025, prior to the open of financial markets.
Akebia will host a conference call on Thursday, March 13, 2024, at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
FAQ
When will Akebia Therapeutics (AKBA) release Q4 and full-year 2024 earnings?
What time is Akebia's (AKBA) Q4 2024 earnings conference call?
How can investors access Akebia's (AKBA) Q4 2024 earnings call?
Where can I find the replay of Akebia's (AKBA) Q4 2024 earnings call?
